ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Leukine Trial in Hospitalized COVID-19 Patients Meets Primary Endpoint
March 03, 2021Partner Therapeutics (PTx) announced top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of inhaled Leukine® (sargramostim, yeast-derived recombinant human GM-CSF) ... -
Partner Therapeutics’ inhaled sargramostim improves lung function in trial
March 02, 2021Partner Therapeutics has reported positive top-line results from the investigator-led study of inhaled Leukine (sargramostim) in hospitalised Covid-19 patients. -
Leukine® significantly improves lung function in hospitalised COVID-19 patients
March 01, 2021In the trial Leukine® (sargramostim, rhuGM-CSF) improved oxygenation in COVID-19 patients with acute respiratory failure by at least a third in over half of those treated.
Pharma Sources Insight January 2025
